Lung densities

QUIBIM

QUIBIM has developed fully automated tool that analyzes CT volume datasets to provide a quantification of different imaging biomarkers: lung volumes, vessel volumes, emphysema volume and ratio through its regional distribution.
Product specifications Information source: Vendor
Last updated: March 10, 2020
General
Product name Lung densities
Company QUIBIM
Subspeciality Chest
Modality CT
Disease targeted COPD, cystic fibrosis, emphysema, pulmonary hypertension
Key-features emphysema %, emphysema volume and lung volume
Suggested use Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population Screening population
Input High resolution CT. Tranverse
Input format
Output One-page structured report: 3D reconstruction of the lungs + emphysema, 3D reconstruction of the lungs + vessel tree, lung and emphysema volume parameters
Output format DICOM Secondary Capture / PDF
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition
Processing time > 10 minutes
Certification
CE Certified, Class IIa
FDA No or not yet
Market presence
On market since 01-2019
Distribution channels
Countries present (clinical, non-research use) 4
Paying clinical customers (institutes) 5+
Research/test users (institutes) 10+
Pricing
Pricing model License
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers